Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Feb 1, 2022
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Study procedures On the first day of admission, all the patients scheduled for cardiac surgery with an on-pump procedure will be asked for a consent for anonymous using of their information. Patients giving permission will be screened for participation in this study, and those fulfil the inclusion/exclusion criteria will be included for further research.
Blood ketone will be measured with StatStrip Glucose/Ketone Meters (Nova biomedical, United Kingdom) using sample leftover from blood gas analysis. No extra blood draw is needed. The levels of ketones will be measured at four time points:
...
Gender
ALL
Eligibility criteria
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- • Inclusion Criteria
- • Aged eighteen years or older
- • Scheduled for open heart surgery
- • Exclusion criteria
- • Diagnosed with type 1 diabetes mellitus or latent auto-immune diabetes in adults
- • Recently used sodium glucose transport co-enzyme 2 (SGLT-2i's) within 2 weeks before surgery)
- • History of recurrent ketoacidosis (two times or more within three months)
- • Emergency surgery
- • (Suspected) pregnancy
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam Zuidoost, Noord Holland, Netherlands
Patients applied
Trial Officials
Jeroen Hermanides, dr
Principal Investigator
Amsterdam Univeristy medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials